天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai Yifei Biotechnology Co. , Ltd.??? ?? ??? ?????.

?? ?:Shanghai Yifei Biotechnology Co. , Ltd.
??:021-65675885
???:customer_service@efebio.com
??:China
URL: http://www.efebio.com
? ?? ?:11974

?? ????

1-(2-hydroxyethyl)thymine22441-51-6C7H10N2O3
F-12244775-31-1C22H27ClN8O3S
CDK12-IN-22244987-03-7C32H32N6O2
CHMFL-PI3KD-3172244992-76-3C21H24ClN5O3S2
HeE1-2Tyr2245195-67-7C33H30N2O6S
MERS-CoV-IN-12245697-92-9C19H17NO2
SGC-AAK1-12247894-32-0C21H25N5O3S
AAPK-252247919-28-2C21H13Cl2N3O2S
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)-2247932-38-1C23H27N3O5
AHR antagonist 5 free base2247950-42-9C25H24FN7
SN-0082249106-01-0C25H19FN2O3S
CRT0066854 hydrochloride2250019-91-9C24H26ClN5S
SHIP2-IN-12252247-80-4C17H13Cl2FN4O
Epitinib succinate2252334-12-4C28H32N6O6
TH54272253744-56-6C20H20Cl2N8O3
CVN4242254706-21-1C24H29F2N5O3
UCM-13062258608-78-3C14H14FNO2S
UMB2982266569-73-5C27H31ClN4O2
Compound 227105-11-53-[4-(?????)??]-2-????227105-11-5C16H14O3
MARK4 inhibitor 12271081-58-2C20H18N6O3
WEE1-IN-32272976-28-8C28H31N7O2
Proquazone?????22760-18-5C18H18N2O
Msr-Ratio2290635-22-0C18H14O3S
2-Methoxy-4-{(E)-3-oxo-3-[(E)-2-oxo-3-(3,4,5- trimethoxybenzylidene)piperidin-1-yl]prop-1-en-1-yl}phenyl acetate2293951-00-3C27H29NO8
(E)-1-[(E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl]-3- (3,4,5-trimethoxybenzylidene) piperidin-2-one2293951-01-4C25H27NO7
anti-TB agent 12294013-78-6C23H19F3N4O3
IMT12304621-31-4C21H21NO4
FLT3-IN-42304799-09-3C23H25N7O2
ENFENAMIC ACID????23049-93-6C15H15NO2
PDE9-IN-12305087-92-5C17H23FN6O2
TD-1652305936-56-3C46H59N7O8S
WSB1 Degrader 12306039-66-5C21H22N2O2
nerolidol acetate?????????2306-78-7C17H28O2
CRT0066101 dihydrochloride(956121-30-5 free base)2308510-39-4
CMP-5 2HCl2309409-79-6C21H22ClN3
BuChE-IN-TM-102313524-95-5C32H38N2O3
TRPV4 agonist-1 free base2314467-59-7C25H22F2N4O2
2,6-Dibromo-4-(hydroxymethyl)phenol3,5-????-4-??????????2316-62-3C7H6Br2O2
LY34051052326428-25-3C26H39N7O3
IRE1α kinase-IN-12328097-41-0C26H26ClFN8
dBRD9 HCl2341840-98-8C40H46ClN7O10
PD-1-IN-222349372-98-9C25H25N5O4
Enbezotinib2359649-81-1C21H21FN6O3
RBN-31432360853-16-1C22H28FN3O4S
5,6-Epoxyergosterol23637-31-2C28H44O2
CWHM-15522368253-58-9C22H27F2N3O
C/EBPα inducer 12374285-52-4C20H12FN3O4
ms481072375070-79-2C23H20FN5O2
Auristatin232375388-36-4C49H84N6O10
K-Ras G12C-IN-42376328-55-9C31H33ClN4O4
DS082107672376334-75-5C31H39N5O2
M2N122376577-06-7C20H16ClN5O2
SU0562376580-08-2C20H16FNO5
Thalidomide-O-C4-NH2 hydrochloride2376990-29-1C17H20ClN3O5
Thalidomide-O-amido-C6-NH2 hydrochloride2376990-31-5C21H27ClN4O6
Tubulin inhibitor 242415761-65-6C22H21N3O3
NAcM-OPT HCl(2089293-61-6 free base)2416146-10-4C23H30Cl3N3O
KB-0742 dihydrochloride2416874-75-2C16H26ClN5
cis VH 032, amine dihydrochloride2376990-32-6C22H31ClN4O3S
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid2377032-39-6
SCR1302377858-38-1C19H13Cl2N3O2S
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea2379727-88-3C24H21ClF3N5O
Antitumor agent-192379727-90-7C24H21ClF3N5O
Reverse transcriptase-IN-12380001-43-2C25H17N7O2
Nampt-IN-52380013-17-0C25H25N5O2
NF-κΒ activator 12387524-59-4C16H11FN2O2S
Pumecitinib2401057-12-1C17H20N8O2S
(S)-ErSO2407860-34-6C22H13F6NO3
PLN-14742408065-32-5C24H37N3O4
HS2712410393-15-4C21H24F3N5O2
ANT33102410688-61-6C6H10FN2NaO5S
Compound TPX-00462411115-73-4
3-amino-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one dihydrochloride2411178-94-2C25H28ClN7O2
Hamaline2411677-02-4C20H19ClN2O
Thalidomide-5-NH2-CH2-COOH2412056-27-8C15H13N3O6
Sivopixant2414285-40-6C25H22ClN5O5
P2Y2R/GPR17 antagonist 12395016-49-4C19H13ClN2O6S
Mito-LND2361564-49-8C43H45BrCl2N3OP
CHIKV-IN-22361289-44-1C23H26N2O2
LMPTP INHIBITOR 1 hydrochloride2310135-38-5C28H37ClN4O
IU1-2482307472-03-1C20H23N3O2
BUR123000-46-6C16H17N5
BCL6-IN-62408882-54-0C27H31FN6O2S
BOS-3182387633-15-8C28H32Cl2N6O3
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride2341796-76-5C28H42ClN5O6S
DDO-72632254004-96-9C14H9F2N3O
DC-TEADin022380228-45-3C19H17NO2S
AGI-431922377491-54-6C23H16ClF3N6O
XL177A2417089-74-6C48H57ClN8O5
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine237402-29-8C20H19N3
BRM/BRG1 ATP Inhibitor-22368900-77-8C20H20N4O2S2
AES-1352361659-61-0C33H29F6N3O5S
HM432392294874-49-8C29H33ClN6
visamminol-3'-O- glucoside2254096-98-3C21H26O10
DS128814792373065-59-7C16H19N3OS
GA-0172351906-74-4C18H21N3O4
ACSS2-IN-22332820-04-7C21H19F2N3O4
BAY 26666052275774-60-0C17H12F4N2O2
SRI-373302322245-42-9C16H19F3N4O2S
SET 22313525-20-9C17H21F3N4O2S
Copyright 2019 ? ChemicalBook. All rights reserved